Moleculin Biotech, Inc.
MBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $19,771 | $4,689 | $91 | $5,744 |
| - Cash | $6,703 | $7,557 | $7,716 | $4,278 |
| + Debt | $390 | $420 | $450 | $478 |
| Enterprise Value | $13,458 | -$2,448 | -$7,175 | $1,944 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$21 | -$29 | $0 | -$31 |
| % Margin | – | – | – | – |
| EBITDA | -$25,378 | -$7,611 | -$5,912 | -$1,851 |
| % Margin | – | – | – | – |
| Net Income | -$25,399 | -$7,640 | -$6,436 | -$1,882 |
| % Margin | – | – | – | – |
| EPS Diluted | -17 | -12.25 | -1,722 | -14 |
| % Growth | -38.8% | 99.3% | -12,200% | – |
| Operating Cash Flow | -$7,223 | -$5,582 | -$4,564 | -$5,083 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$7,223 | -$5,582 | -$4,564 | -$5,083 |